News Feb 02, 2023

Leaders of State Capital Investment Corporation (SCIC) took a business trip and wished a Happy Lunar New Year at Traphaco Joint Stock Company

On February 2^nd, 2023, The Leadership Team of the State Capital Investment Corporation (SCIC) had a meeting to visit, work and wish a Happy Lunar New Year to the Board of Managements of Traphaco Joint Stock Company.

Attending the meeting were Mr. Nguyen Quoc Huy - Member of the Board of Directors, CEO of SCIC; Mr. Nghiem Xuan Da – Vice CEO of SCIC; together with the Leaders of the investment capital management board 3 and the specialist in charge of business. Welcoming at Traphaco were Mr. Tran Tuc Ma - Secretary of the Party Committee, CEO of the company and members in the Board of Managements of the company.

CEO Tran Tuc Ma reports on production and business activities in 2022

On behalf of the Board of Managements of the company, Mr. Tran Tuc Ma reported on business activities in 2022 and some important orientations in 2023. Mr. Nguyen Quoc Huy sent New Year greetings to the Board of Manamgents of the company. Traphaco Joint Stock Company and highly appreciate the efforts of the Board of Managements and all employees of the company, worthy of being a Hero unit that has been awarded the First Class Labor Medal by the State twice.

On the same day, SCIC's delegation visited and worked at 2 Traphaco factories: Traphaco's 4.0 smart pharmaceutical factory in Hung Yen and the first and largest GMP-WHO oriental medicine factory in Vietnam Traphaco CNC (Hung Yen). During the visit, the delegation was introduced with Traphaco's modern, large-capacity, self-contained and fully automated production lines.

Mr. Nguyen Quoc Huy - Member of the Board of Directors, CEO of SCIC shared at the meeting (the middle)

Traphaco Joint Stock Company is on the list of state capital managed by SCIC. Traphaco pioneered equitization in 1999 and transformed its operating model in the direction of self-reliance, creativity, and production of products that the market needs and is really useful to consumers.

If comparing the figures that Company achieved in 2022 with the number in 2000, when the business was newly equitized, Traphaco's revenue increased 43 times, profit before tax increased 28.5 times, profit after tax increased 27 times.

2022 is considered a successful year for Traphaco when the company exceeded the plan in both revenue and profit, successfully held the 50^th Anniversary Celebration of the traditional day and received the First Class Labor Medal for the first time twice. Following the growth momentum, entering January 2023, Traphaco recorded positive signals from the market, achieving 50% of the planned revenue in January & February. Starting from 2023, Traphaco will split the entire sales system into two groups of traditional medicines - In addition to traditional medicines, invest in human and material resources, and separate sales policies with many incentives to promote the two pillars for together development.

Currently, Traphaco has been leading in the field of herbal medicine in Vietnam and is expanding its development strategy into the field of non herbal medicine. The strategy of "Maintaining the No. 1 position in Herbal Medicine - investing in developing high-quality Western medicines" has been vigorously implemented in the Company, has been creating a strong momentum for the Company to have a new development momentum after 50 years of operation.

Through the growth of a typical enterprise like Traphaco, it is very clear that the motivation from equitization has brought opportunities and promoted the development of enterprises after equitization.

Some pictures: